The University of Chicago Header Logo

Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib.

Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib. JAAD Case Rep. 2023 Jul; 37:119-122.

View in: PubMed